SCHEMBL10140801

SCHEMBL10140801

CC(C)c1ccn(-c2ccc(I)cc2)c(=O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
ALOX15 P16050 2/20 0.38
HTT P42858 2/20 0.38
ATM Q13315 1/20 0.38
MGLL Q99685 2/20 0.37
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
RECQL P46063 1/20 0.36
FAAH O00519 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALKBH5 Q6P6C2 1/20 0.35
PTGS2 P35354 1/20 0.33
KCNH2 Q12809 1/20 0.33
MCHR1 Q99705 1/20 0.33
RNASEH1 O60930 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MDM4 O15151 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL889379 0.87 MGLL (0.48) ALDH1A1ALOX15HTTATMMGLL
SCHEMBL12438375 0.84 F2 (0.44) ALDH1A1ALOX15HTTATMMGLL
SCHEMBL4627329 0.82 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2KCNH2MCHR1KDM4E
SCHEMBL13156302 0.77 ALDH1A1 (0.44) ALDH1A1ALOX15HTTATMMGLL
SCHEMBL10140954 0.74 LMNA (0.47) ALDH1A1ALOX15HTTATMMGLL
SCHEMBL10059817 0.73 ALDH1A1 (0.41) ALDH1A1ALOX15HTTATMMGLL
SCHEMBL10121965 0.70 MGLL (0.42) ALDH1A1ALOX15HTTATMMGLL
SCHEMBL799134 0.70 PTGS2 (0.39) ALDH1A1ALOX15HTTMGLLLMNA
SCHEMBL12332876 0.69 MAPT (0.40) ALDH1A1ALOX15HTTATMMGLL
SCHEMBL10059788 0.69 ALDH1A1 (0.57) ALDH1A1ALOX15HTTATMMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012021704-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed
WO-2011081918-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC (US) 2011-07-07 WO disclosed
WO-2011031904-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC (US) 2011-03-17 WO disclosed
WO-2011031934-A1 HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2011-03-17 WO disclosed